US EditionDECO warns of inequalities in access to medicines and asks for a review of reimbursements
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
DECO ProTeste warned yesterday of inequalities in access to medicine in Portugal, calling for the revision of the reimbursement system, which says it leaves more vulnerable citizens unprotected. In a study of the 15 prescription drugs with the highest sales value in Portugal, he concluded that, although the country does not have the highest drug prices, the current reimbursement system leaves some vulnerable citizens unprotected, “compromising a…
In a study of the 15 prescription drugs with the highest sales value in Portugal, he concluded that, although the country does not have the highest drug prices, the current reimbursement system leaves some vulnerable citizens unprotected, “compromising access to essential health care”. The analysis compared the prices of these 15 drugs - which include drugs used for diabetes, cholesterol, chronic heart failure, gastroesophageal reflux, risk of b…
Association calls for the revision of the reimbursement system, which says it leaves vulnerable citizens unprotected
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
